title: Treatment of comorbid bipolar disorder and anxiety disorders: A great challenge to modern psychiatry.
authors.affiliation: Department of Clinical and Experimental Medicine, University of Parma, Parma, Italy Mood Disorders Program, Tufts Medical Center, Boston, MA, USA andrea.amerio@studenti.unipr.it.
authors.forename: Andrea
authors.initials: A
authors.lastname: Amerio
authors.affiliation: Department of Mental Health, Local Health Agency, Parma, Italy.
authors.forename: Matteo
authors.initials: M
authors.lastname: Tonna
authors.affiliation: Unit of Public Health, Department of Biomedical, Biotechnological and Translational Sciences, University of Parma, Parma, Italy.
authors.forename: Anna
authors.initials: A
authors.lastname: Odone
authors.affiliation: Institute of Psychiatry, King's College London, London, UK.
authors.forename: Brendon
authors.initials: B
authors.lastname: Stubbs
authors.affiliation: Department of Mental Health, Local Health Agency, Parma, Italy Department of Psychiatry and Pharmacology, Tufts University Medical School, Boston, MA, USA.
authors.forename: S Nassir
authors.initials: SN
authors.lastname: Ghaemi
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage; D001569:Benzodiazepines / Q000008:administration & dosage*; D001714:Bipolar Disorder / Q000188:drug therapy*; D015283:Citalopram / Q000008:administration & dosage*; D015897:Comorbidity; D006801:Humans; D008297:Male; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy*; D000077152:Olanzapine; D014635:Valproic Acid / Q000008:administration & dosage*
chemical_list: D014150:Antipsychotic Agents; D015283:Citalopram; D001569:Benzodiazepines; D014635:Valproic Acid; D000077152:Olanzapine